Tiziana Life Sciences Ltd (TLSA)
NASDAQ: TLSA · Real-Time Price · USD
1.390
-0.020 (-1.42%)
At close: Feb 11, 2026, 4:00 PM EST
1.400
+0.010 (0.72%)
After-hours: Feb 11, 2026, 7:07 PM EST
Tiziana Life Sciences Market Cap
Tiziana Life Sciences has a market cap or net worth of $177.4 million as of February 11, 2026. Its market cap has increased by 120.95% in one year.
Market Cap
177.40M
Enterprise Value
166.42M
1-Year Change
120.95%
Ranking
Category
Stock Price
$1.39
Market Cap Chart
Since October 21, 2021, Tiziana Life Sciences's market cap has increased from $145.96M to $177.40M, an increase of 21.54%. That is a compound annual growth rate of 4.63%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 10, 2026 | 179.95M | 1.64% |
| Dec 31, 2025 | 177.05M | 133.12% |
| Dec 31, 2024 | 75.95M | 34.82% |
| Dec 29, 2023 | 56.33M | -7.14% |
| Dec 30, 2022 | 60.66M | -35.06% |
| Dec 31, 2021 | 93.41M | -36.00% |
| Oct 21, 2021 | 145.96M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Humacyte | 181.09M |
| Galectin Therapeutics | 180.52M |
| Sagimet Biosciences | 180.49M |
| Prelude Therapeutics | 178.80M |
| Milestone Pharmaceuticals | 178.78M |
| Editas Medicine | 177.67M |
| C4 Therapeutics | 176.38M |
| Tenaya Therapeutics | 175.69M |